Back
Immuron Ltd. 10K Form
Sell
23
IMRN
Immuron Ltd.
Last Price:
$1.57
Seasonality Move:
-12.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMRN News And Ratings
See the #1 stock for the next 7 days that we like better than IMRN
IMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.7M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.12 |
| Price / Book: | 1.52 |
Profitability
| EPS (TTM): | -0.58510 |
|---|---|
| Net Income (TTM): | $-3.4M |
| Gross Margin: | $3.1M |
| Return on Equity: | -53.91% |
| Return on Assets: | -45.97% |
Immuron Ltd. Earnings Forecast
Key Immuron Ltd. Financial Ratios
-
The Gross Profit Margin over the past 27 years for IMRN is 64.71%.
-
The Selling, General & Administrative Expenses for IMRN have been equal to 108.91% of Gross Profit Margin.
-
The Research & Development expenses have been 49.37% of Revenue.
-
The Net Earning history of IMRN is -71.58% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Immuron Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMRN |
| CUSIP: | 45254U |
| Website: | immuron.com.au |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.8 |
| Quick Ratio: | 5.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IMRN Technical Analysis vs Fundamental Analysis
Sell
23
Immuron Ltd. (IMRN)
is a Sell
Is Immuron Ltd. a Buy or a Sell?
-
Immuron Ltd. stock is rated a SellThe current Immuron Ltd. [IMRN] share price is $1.55. The Score for IMRN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.